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Fifty five thermophilic Campylobacter spp. strains were isolated from cecum of broilers, cecum and 
colon of pigs and from human feces. The strains were identified as Campylobacter jejuni and 
Campylobacter coli. The more prevalent species in broilers and humans was C. jejuni and in pigs C. coli. 
In the framework of this study, sensitivity to tetracycline in isolated strains of C. jejuni and C. coli was 
tested by E-test. In 16 tested strains isolated from broilers, 56.25% were resistant to tetracycline. 
Resistance occured more frequent in C. coli strains (66.67%). In 15 strains of termophilic Campylobacter 
spp. isolated from pigs the percentage of resistant strains was 80%. Resistance was detected more 
often in C. coli (90.00%) isolates. The percentage of resistant C. jejuni strains from pigs was 60.00%. 
Resistance to tetracycline occurred in 29.17% of 24 thermophilic Campylobacter spp. strains isolated 
from humans. Generally, strains of thermophilic campylobacters, especially C. coli isolated in pigs are 
more frequent resistant to tetracycline than strains isolated in poultry and human. Therefore, attention 
should be directed to the tetracycline application monitoring in swine farming in order to prevent 
resistance appearance in animal strains and its subsequent spread to human strains.  
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INTRODUCTION 
 
One of the most important bacterial zoonosis is campylo-
bacteriosis. Campylobacter genus consists of 18 species, 
of which thermophilic campylobacters: Campylobacter 
jejuni, Campylobacter coli, Campylobacter lari, Campylo-
bacter upsaliensi are the most frequent causative agents 
of the disease in humans. Thermophilic Campylobacter 
species are fastidious bacteria which require: special 
media supplemented with antibiotics inhibiting other gut 
bacteria growth, microaerophylic environment (5% O2, 
10% CO2 and 85% N2) and 42°C temperature for their 
growth. Animals very rarely develop a disease with very 
mild symptoms. The disease is a result  of  an  infection  
with one of  virulent  strains,  an  intercurrent  infection  or 
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low immunity level in infected individuals (López et al., 
2002). Animals are colonized by Campylobacter spp. in 
different proportions. Poultry in age of two to tree weeks 
is 50 - 90% colonized with termophilic Campylobacter 
spp. (Newel, 2002). Pigs are less colonized by the same 
bacteria than poultry. 
C jejuni and C. coli are the most important etiologic 
agents of bacterial intestinal infections actually present in 
the world, with 400,000000 cases every year. An 
important factor in the intestinal campylobacteriosis 
development is a low infective dose of 500 bacteria only 
(Walker et al., 1986). Increase of resistance in genus 
Campylobacter to the antibiotics most frequently used in 
therapy of campylo-bacteriosis in humans, recently 
becomes alarming. Many authors in the world report on 
resistance of Campylobacter to tetracycline (Aarestrup et 
al.,   1997;   Fernández   et    al.,   2000;   Aarestrup   and 
  
 
 
 
Engberg, 2001; Aquino et al., 2002; Ge et al., 2002; 
Avrain et al., 2003; Butzler, 2004). Having in mind the 
fact that a very small number of investigations on 
thermophilic Campylobacter spp. sensitivity to the drugs 
were available in our country, we decided to determine 
the sensitivity to tetracycline of thermophilic Campylobac-
ter isolated from animals and humans. 
 
 
MATERIALS AND METHODS 
 
Scrappings of broiler cecum surfaces, scrappings of pigs cecum 
and colon surfaces, as well as human faeces were used as a 
material to study. For thermophilic Campylobacter isolation from 
animals, following procedures were used: 
 
1. Immediately after collection, samples were, in aim to obtain 
individual colonies, diluted and then inoculated on Karmali agar and 
Skirrow agar. Inoculated plates were placed in pots for anaerobes 
and then, by Campy Pak, BBL bags, microaerophilic conditions 
were created. In the laboratory, transported pots were transferred in 
thermostats and incubated in microaerophilic conditions on 42°C for 
48 h. 
2. After incubation period, individual colonies were picked up and 
slides dyed with 2% carbol fuchsin for microscopy were made. 
Campylobacter spp. grow forming colonies of characteristic mor-
phology were visualised. Some formed a confluental growth with 
the line of inoculation. 
3. To obtain pure culture of thermophilic Campylobacter spp. 
individual colonies were subcultured on Karmali or blood agar 
plates. 
 
For further investigations isolated bacteria were storred in BHI 
(brain-heart-infusion- media) with 30% glicerol at temperature of -
70°C (Kam et al., 2001). Strains from human feces were isolated on 
Columbia agar base supplemented with 5% sheep blood and 
antibiotics (cefoperazone 1.5 g/L, colistin 106 U, vancomycin 1 g/L, 
amphotericin B 0.2 g/L) (bioMérieux, Marcy l’Etoile, France), 
following incubation in a jar under micro aerobic conditions 
(bioMérieux, Marcy l’Etoile, France), at 42°C, for 48 h. Isolated 
bacteria were identified by classic and commercial biochemical 
tests. Classic biochemical tests included catalase test, oxidase test, 
hippurate hydrolysis test, indoxyl acetate hydrolysis, fast H2S test, 
susceptibility to cephalotine and nalidixic acid (Aarestrup et al., 
1997; Jain et al., 2005). Final identification of Campylobacter spp. 
was performed by automatic identification system API Campy (Bio 
Mérieux, France) following producers’s instructions. Assessment of 
thermophilic C. jejuni and C. coli susceptibility to tetracycline was 
performed by E-test (AB BIODISK, Solna, Sweden). E-test was 
performed by recomendations of the manufacturer. 
 
 
RESULTS 
 
Four hundred forty-nine specimens obtained by scrapp-
ing of broiler caecum surfaces, scrapping of pigs caecum 
and colon surfaces and human faeces were investigated. 
Out of the samples collected, fifty five Campylobacter 
spp. strains were isolated, by conven-tional and automa-
tised microbiology tests 32 C. jejuni strains and 23 C. coli 
strains were identified (Table 1). C. jejuni is predominant 
in humans and broilers and C. coli is predominant in pigs. 
Five of 17 C.  jejuni  strains  isolated  from  humans  were  
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resistant to tetracycline. Five of 10 C. jejuni strains 
isolated from broilers and 3 of 5 strains from pigs were 
resistant to tetracycline (Table 2). Nine of 10 C. coli 
strains isolated from pigs were resistant to tetracyclin 
(Table 3). Four of 6 C. coli strains isolated from broilers 
and 2 of 7 strains from humans were resistant to tetra-
cycline. The lowest frequency of Campylobacter strains 
resistant to tetracycline was found in strains isolated from 
humans 29.17%. In strains isolated from broilers resis-
tance frequency to tetracycline was 56.25%. Very high 
frequency of resistance to  tetracycline was found in 
strains isolated from pigs  (80.00%) (Table 4).  
 
 
DISCUSSION 
 
Beginning with eighties of the last century onward, a 
selection and spreading of resistant strains of thermo-
philic Campylobacter spp. in humans occurred. This 
phenomenon has been attributed to uncontrolled antibio-
tics (especially tetracycline) use in veterinary medicine as 
a growth promoters, also in prophylaxis and therapy 
(Desmonts et al., 2004). In human medicine tetracyclines 
have been used without control, too (Golub et al., 2008). 
Sensitivity to tetracycline was studied in 55 C. jejuni 
and C. coli strains isolated from humans, broilers and 
pigs. Twenty four strains were isolated from humans, 16 
from broiler and 15 strains were isolated from pigs. 
Based on the minimum inhibitory concentration (MIC) 
values obtained by E-test, resistance to tetracycline of C. 
jejuni and C. coli isolated from humans was 29.17%. Our 
results are in accordance to the results of others (Krause 
and Ullman, 2003; Boyanova et al., 2004). A lower level 
of resistance to tetracycline, ranging from 12 to 16%, was 
reported in Australia, Turkey and India (Alfredson et al., 
2003; Oncul et al., 2003; Jain et al., 2005). Very low level 
of thermophilic Campylobacter spp. isolated from human, 
resistant to tetracyclines, only 1.8%, was registered in 
Chile (Fernández et al., 2000). High percentage of 
resistant thermophilic Campilobacter strains isolated from 
humans, ranging from 43 to 85%, report authors in USA, 
Spain and Finland (Ge et al., 2002; Garcia-Campos et al., 
2003; Hakanen et al., 2003; Gupta et al., 2004), a 
surprising fact having in mind that, developed countries 
use antibiotics as controlled and based only on thera-
peutic indications and antibiogram results. Annoying is 
the trend of resistance increase to tetracycline in many 
countries (Gaudreau and Gilbert, 1998; Moore et al., 
2005). 
The resistance to tetracycline of C. jejuni and C. coli 
strains isolated from broilers was 56.25%. The more 
resistant species was C. coli (66.67%). Similar results are 
reported in other studies (Sáenz et al., 2000; Avrain et 
al., 2003; Ishihara et al., 2004, Luangtongkum et al., 
2008, Baster and Essack, 2008). Great number of 
authors report lower percentages of resistance (Looveren 
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Table 1. Thermophilic Campylobacter spp in broiler chickens, pigs and humans (N° 
and %). 
 
Host Number of strains isolated C. jejuni C. coli 
Broilers chickens 16 10 (62.50%) 6 (37.50%) 
Pigs 15 5 (33.33%) 10 (66.67%) 
Humans 24 17 (70.83%) 7 (29.17%) 
 
 
 
Table 2. Results of tetracycline MIC determination by E-test for C. jejuni isolated from broiler chickens, pigs and 
humans. 
 
Source of strains  N° of strains *MIC range **MIC50 ***MIC90 Resistance (%) 
Broiler chickens 10 0.016 - >256 24.00 >256 50.00 
Pigs 5 0.016 - >256 >256 >256 60.00 
Humans 17 0.006 - >256 0,25 >256 29.41 
 
* Minimum inhibitory concentration, ** Minimum inhibitory concentration required to inhibit the growth of 50% of organisms, 
*** Minimum inhibitory concentration required to inhibit the growth of 90% of organisms. 
 
 
 
Table 3. Results of tetracycline MIC determination by E-test for C. coli isolated from broiler chickens, pigs and humans. 
 
Source of strains N° of strains *MIC range **MIC50 ***MIC90 Resistance (%) 
Broiler chickens 6 < 0.016 - >256 >256 >256 66.66 
Pigs 10 3.00 - >256 48.00 >256 90.00 
Humans 7 0.032 – >256 4.00 >256 28.57 
 
* Minimum inhibitory concentration, ** Minimum inhibitory concentration required to inhibit the growth of 50% of organisms, 
*** Minimum inhibitory concentration required to inhibit the growth of 90% of organisms. 
 
 
 
Table 4. Results of tetracycline MIC determination by E-test for Campylobacter strains isolated from broiler chickens, 
pigs and humans. 
  
Source of strains No of strains *MIC range **MIC50 ***MIC90 Resistance (%) 
Broiler chickens 16 < 0.016 - >256 24.00 >256 56.25 
Pigs 15 0.016 - >256 14.00 >256 80.00 
Humans 24 0.006 - >256 0.06 >256 29.16 
 
* Minimum inhibitory concentration, ** Minimum inhibitory concentration required to inhibit the growth of 50% of organisms, *** 
Minimum inhibitory concentration required to inhibit the growth of 90% of organisms. 
 
 
 
et al., 2001; Fallon et al., 2003; Ledergerber et al., 2003, 
Han et al., 2009). Aarestrup and Wegener (1999) in 
Denmark were found low resistance level to tetracyclines 
in C. jejuni/coli strains isolated from poultry (2%). Low 
resistance level is due to controlled use of tetracycline in 
poultry farms in this country.The resistance to tetracycline 
of C. jejuni and C. coli strains isolated from pigs was 
80.00% and it was significantly higher than resistance in 
strains isolated from humans. The more resistant species 
was C. coli (90.00%) and was significantly higher than 
the strains isolated in humans. Similar results are 
reported in other studies (Burch, 2002; Hart et al., 2004). 
Some   authors  report  lower  percentages  of  resistance 
(Gebreyes et al., 2005; Schuppers et al., 2005). 
Aarestrup and Wegener (1999) in Denmark were found a 
low resistance level to tetracyclin in C. jejuni/coli strains 
isolated from pigs (1%). 
Four mechanisms in resistance development are 
included: efflux system, tetracycline modification, protec-
tion of ribosomal coupling point for tetracycline and 
mutation in 16S rDNA. In C. jejuni and C. coli the 
resistance is related to self-transmissive plasmids 
(Aarestrup and Engberg, 2001). The consequence is a 
possible transmission of resistance between Campylo-
bacter spp. strains and transmission of resistance genes 
on bacteria of other genera (Speer et al., 1992). The high 
  
 
 
 
percentage of resistant Campylobacter strains to 
tetracycline could be explained by uncontrolled use of 
oxytetracycline in poultry farming and swine farming as a 
prophylaxis and its use in sub-optimal dosage to growth 
promotion and in high dosage in therapy of infections 
generally caused by gram-negative bacteria.  
In conclusion, since C. coli is more frequent resistant 
to tetracycline than C. jejuni, as well as strains isolated in 
pigs, attention should be directed to the tetracycline appli-
cation monitoring in swine farming in order to prevent 
resistance appearance in animal strains and its sub-
sequent spread to human strains. Therefore, instead of 
tetracycline and oxytetracycline use, somewhat a better 
susceptibility should be realized by the use of doxycycline 
which has better pharmacokinetic properties and 
distribution in the body (Prescott, 2006). 
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